Antimicrobial Resistance

Project Partner

Our international group of experts

anti

Joint Programming Initiative on Antimicrobial Resistance

 

Composition of Working Group
Name Affiliation Country Nature of contribution  
Till T. Bachmann University of Edinburgh UK UK Coordinator, Diagnostic (Dx) Innovator  
Alex van Belkum Biomerieux FR Dx Industry  
A MacGowan North Bristol NHS Trust UK Health, Policy  
Aman Russom KTH Royal Institute of Technology SE Dx Innovator  
Andrew Shepherd Omega Diagnostics UK Dx Industry  
Ann Van den Bruel NIHR Diagnostic Evidence Cooperative UK Dx Implementation, Health  
Annika Eriksson HemoCue AB SE Dx Industry  
Barbara Fallowfield British In Vitro Diagnostics Association UK Dx Industry Association  
Bill Rodriguez Foundation for Innovative New Diagnostics CH NGO, global PRND Dx dev. & impl.  
Carla Deakin NICE UK Governmental, Dx assessment  
Eiichi Tamiya Osaka University JP Dx Innovator  
Francis Moussy World Health Organization, Observer CH IGO, global AMR Dx implementation  
Franck Molina European Diagnostics Cluster Alliance FR Dx Industry Network  
Frank Apostel R-Biopharm DE Dx Industry  
Frank Bier Fraunhofer IZI DE Dx Innovator, research organisation  
Gerd Luedke Curetis GmbH DE Dx Industry  
Guido Werner Robert Koch Institute DE Federal Public Health Institute  
Gunnar Simonsen University of Tromsø NO Health  
Gyorgy Abel Lahey Hospital, Harvard University US Health  
Herman Goossens Antwerp University BE Health, Policy  
Jacob Moran-Gilad Ben-Gurion University & Ministry of Health IL Policy, Health, Dx Innovator  
James Fraser Chipcare CA Dx Industry  
Jean-François de Lavison Ahimsa Fund FR Non-profit Organization  
John Hays Erasmus University Medical Center NL Dx Innovator, academic/medical  
John Rex AstraZeneca US Pharma Industry  
Jordi Vila University of Barcelona ES Health  
Karsten Becker University Hospital Münster, DGHM DE Health  
Kate Templeton NHS Lothian UK Health, Clinical Scientist  
Kirsten Miller-Duys Hyrax Biosciences SA Dx Industry  
Konstantinos Mitsakakis Hahn-Schickard, University of Freiburg DE Dx Innovator, research organisation  
Manica Balasegeram GARD/DNDI CH NGO, drug development  
Mark Woolhouse University of Edinburgh UK Infectious Disease Epidemiology  
Neil Butler Spectromics UK Dx Industry  
Neil Woodford Public Health England UK Health, Policy  
Paul Savelkoul Maastricht University NL Health  
Petra Gastmeier Charite Belin, Infect Control 2020 DE Health, Policy  
Philippe Lagace Wiens University of Manitoba CA Health  
Ramanan Laxminarayan Center for Disease Dynamics, Economics & Policy US/IN NGO, Public Health  
Rosanna Peeling London School of Hygiene &Tropical Medicine UK Dx Innovator, academic/global health  
Saturnino Luz Usher Institute UK Data Science  
Soeren Schubert Max von Pettenkofer Institute Munich DE Health  
Stephan Harbarth University of Geneva CH Health  
Sue Hill NHS England UK Health, Policy  
Tracy Merlin University of Adelaide AU Health Technology Assessment  
Taslimarif Saiyed Centre for Cellular and Molecular Platforms IN Dx Innovator  
Thomas Wichelhaus University Frankfurt; Paul Ehrlich Society DE Health  
Tjeerd van Staa Farr Institute Health Informatics Research UK Data Science  
Valentina Di Gregori University of Bologna IT Infectious Disease Epidemiology  
Wouter van der Wijngaart KTH Royal Institute of Technology SE Micro- and nanosystems  
Wilfried von Eiff HHL Leipzig DE Health economics